electroCore Expands Intellectual Property Portfolio
ECOR 01.07.2025
About Gravity Analytica
Recent News
- 01.07.2025 - electroCore Expands Intellectual Property Portfolio
- 12.17.2024 - electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness
- 11.20.2024 - electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 Award
Recent Filings
- US Patent No. 12,168,128 entitled “Systems and Methods for Treating a Medical Condition” was issued on
December 17, 2024 , and generally relates to a stimulator transmitting electrical impulses to the trigeminal nerve in the patient’s head to treat a medical condition. The stimulator is linked to a software program downloadable onto a mobile device that can control a parameter of the electrical impulse and authorize the stimulator to transmit the electrical impulse. - US Patent No. 12,168,121 entitled “Devices and Methods for Treating or Preventing Developmental Disorders” was issued on
December 17, 2024 , and generally relates to a method for treating a developmental condition or disorder in a fetus of a pregnant woman by delivering an electrical impulse having a frequency range of about 1 kHz to about 20 kHz to a nerve within a woman. - US Patent No. 12,172,015 entitled “Systems and Methods for Initial Provisioning and Refilling of Medical Devices” was issued on
December 24, 2024 , and generally relates to a medical device configured to generate electrical impulses for a period of time or a single dose, and a processor configured to interface with a storage medium, such as an RFID card, barcode, QR code or the like, to erase or scramble the card after a specific number of single doses have been applied by the device (i.e., a medical device that can be “refilled” for further use with a smart card). - US Patent No. 12,172,016 entitled “Non-Invasive Electrical Stimulation for Medical Disorders” was issued on
December 24, 2024 , and generally relates to systems and methods for treating Parkinson’s disease with non-invasive vagal nerve stimulation. - US Patent No. 12,179,012 entitled “Devices and Methods for Non-Invasive Nerve Stimulation” was issued on
December 31, 2024 , and generally relates to a device and method for treating a disorder in a patient. The device comprises a housing and an energy source configured to generate an electrical impulse and transmit the electrical impulse through an outer skin surface to a target nerve within the patient. The electrical impulse comprises bursts of alternating pulses with each burst having a duration of about 800 to about 2,000 microseconds.
About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in
For more information, visitwww.electrocore.com.
Forward-Looking StatementsThis press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about electroCore's business prospects and clinical and product development plans; its pipeline or potential markets for its technologies; the timing, outcome and impact of regulatory, clinical and commercial developments; the issuance of
